Infants aged 12 months can mount adequate serotype-specific IgG responses to pneumococcal polysaccharide vaccine

J Allergy Clin Immunol. 2010 Aug;126(2):395-7. doi: 10.1016/j.jaci.2010.05.008. Epub 2010 Jun 26.

Abstract

This is the first study examining serotype-specific IgG responses following immunization with the polysaccharide vaccine Pneumovax® in infants aged 12 months in the absence of prior pneumococcal conjugate vaccine priming.

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Bacterial / blood
  • Antibodies, Bacterial / immunology*
  • Antibody Specificity / immunology*
  • Female
  • Humans
  • Immunoglobulin G / blood
  • Immunoglobulin G / immunology*
  • Infant
  • Male
  • Pneumococcal Infections / blood
  • Pneumococcal Infections / immunology
  • Pneumococcal Infections / prevention & control
  • Pneumococcal Vaccines / administration & dosage*
  • Pneumococcal Vaccines / immunology*
  • Streptococcus pneumoniae / immunology*

Substances

  • Antibodies, Bacterial
  • Immunoglobulin G
  • Pneumococcal Vaccines